Related Experiment Videos

First-line treatment in HIV: many paths to success

¹CRI New England, Harvard Vanguard Medical Associates, and Harvard Medical School, Boston, Massachusetts, USA.

Journal of Acquired Immune Deficiency Syndromes (1999)

|August 30, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials.

The Journal of antimicrobial chemotherapy·2026

Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens.

Frontiers in immunology·2024

Antiretrovirals and Weight Change: Weighing the Evidence.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study.

Frontiers in immunology·2023

Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study.

Frontiers in immunology·2022

Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis.

AIDS patient care and STDs·2014

See all related articles